Skip to main content

FDA approves Teligent's ANDA

The Food and Drug Administration approved the abbreviated new drug application for Teligent Inc.'s (Nasdaq: TLGT) Clobetasol Propionate Cream USP, 0.05% lifting the stock price 50 cents to close at $3.52.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.